Biggest News Aggregation in the World
📰 Section Head News

Page 11 - Section Head News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Section Head. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Yumanity Therapeutics : VISTA blocking immunotherapy engineered to address immunosuppression in the tumor microenvironment (TME) Phase 1 initial data readout anticipated by end of 2023 - Form 8-K

Kineta, Inc. , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the first patient has been... | April 12, 2023
United States Shawn Iadonato Evan Yu Jacques Bouchy John Mullaly Exchange Commission

Kineta Announces First Patient Dosed in Phase 1/2 Clinical Study of KVA12123 for Advanced Solid Tumors

12.04.2023 - VISTA blocking immunotherapy engineered to address immunosuppression in the tumor microenvironment (TME) Phase 1 initial data readout anticipated by end of 2023 SEATTLE, April 12, 2023 (GLOBE NEWSWIRE) - Kineta, Inc. (Nasdaq: KA), a ... Seite 1
Evan Yu Clinical Research Division Fred Hutchinson Cancer Center Section Head Cancer Medicine Hutchinson Cancer Center

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science